Strategies for combination therapy in oncology: Part two – Working with the “status quo”
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Healthcare Claims Analytics Platform (HCAP) is a modular, dynamic, rapidly updating data-visualization tool that provides streamlined analysis of patient, Health Care Practitioner (HCP), and Health Care Organization (HCO) level data to support decision making and insight generation. HCAP supports clients in visualizing advanced analytics to provide intelligence on patients, physicians, hospitals, and the broader healthcare market. With the information obtained from HCAP, clients are better informed to make key strategic decisions.
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In...
It is difficult to imagine someone who hasn’t called on antibiotics to help them through an infection or protect them during a surgery. Thanks to developments...
Five consultants had five posters accepted and one of our consultants presents during a podium session at this year’s event. Myriam Mirza with Merck:...
CRA is a proud sponsor of the event. Bhavesh Patel and Charlotte Poon present the session titled “Access Opportunities for Rare Disease In and Out of Europe.”...